CD8+ T cells are the essential effector cells against tumors, and the tumor-related antigens of Major Histocompatibility Complex I (MHC I) are recognized by activated CD8+ T cells, which then destroy tumor cells by activating their T cell receptors (46). This evidence concerns the gene CD8A and neoplasm.